118 related articles for article (PubMed ID: 35699029)
1. 6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities.
Travier N; Fu M; Romaguera A; Martín-Cantera C; Fernández E; Vidal C; Garcia M;
Arch Bronconeumol; 2021 Aug; 57(8):521-527. PubMed ID: 35699029
[TBL] [Abstract][Full Text] [Related]
2. 6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities.
Travier N; Fu M; Romaguera A; Martín-Cantera C; Fernández E; Vidal C; Garcia M;
Arch Bronconeumol (Engl Ed); 2020 May; ():. PubMed ID: 32402549
[TBL] [Abstract][Full Text] [Related]
3. Reflections on the Implementation of Low-Dose Computed Tomography Screening in Individuals at High Risk of Lung Cancer in Spain.
Garrido P; Sánchez M; Belda Sanchis J; Moreno Mata N; Artal Á; Gayete Á; Matilla González JM; Galbis Caravajal JM; Isla D; Paz-Ares L; Seijo LM
Arch Bronconeumol; 2017 Oct; 53(10):568-573. PubMed ID: 28416207
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
[TBL] [Abstract][Full Text] [Related]
5. Lung Cancer Screening: Use of Low-Dose Computed Tomography.
Martínez Pérez E; de Aguiar Quevedo K; Arrarás Martínez M; Cruz Mojarrieta J; Arana Fernández de Moya E; Barrios Benito M; Hinarejos Parga S; Cervera Deval J; Peñalver Cuesta JC
Arch Bronconeumol (Engl Ed); 2019 Oct; 55(10):526-531. PubMed ID: 31036378
[TBL] [Abstract][Full Text] [Related]
6. Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography.
Mesa-Guzmán M; González J; Alcaide AB; Bertó J; de-Torres JP; Campo A; Seijo LM; Ocón MM; Pueyo JC; Bastarrika G; Lozano MD; Pío R; Montuenga LM; García-Granero M; Zulueta J
Arch Bronconeumol (Engl Ed); 2021 Feb; 57(2):101-106. PubMed ID: 32600849
[TBL] [Abstract][Full Text] [Related]
7. Lung Cancer Screening: Survival in an Extensive Early Detection Program in Spain (I-ELCAP).
Cervera Deval J; Barrios Benito M; Peñalver Cuesta JC; Martínez Pérez E; Sandiego Contreras S; Cruz Mojarrieta J; de Aguiar Quevedo K; Arraras Martínez M; Arana E
Arch Bronconeumol; 2022 May; 58(5):406-411. PubMed ID: 35312494
[TBL] [Abstract][Full Text] [Related]
8. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
9. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
10. LDCT lung cancer screening in populations at different risk for lung cancer.
Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
[TBL] [Abstract][Full Text] [Related]
11. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
12. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer History.
Maller B; Simmons VN; Byrne MM; Tanvetyanon T
Clin Lung Cancer; 2021 Jul; 22(4):e629-e636. PubMed ID: 33441268
[TBL] [Abstract][Full Text] [Related]
14. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
[TBL] [Abstract][Full Text] [Related]
15. Screening baseline characteristics of early lung cancer on low-dose computed tomography with computer-aided detection in a Chinese population.
Liu Y; Luo H; Qing H; Wang X; Ren J; Xu G; Hu S; He C; Zhou P
Cancer Epidemiol; 2019 Oct; 62():101567. PubMed ID: 31326849
[TBL] [Abstract][Full Text] [Related]
16. Lung Cancer Screening: Computed Tomography Radiation and Protocols.
Murugan VA; Kalra MK; Rehani M; Digumarthy SR
J Thorac Imaging; 2015 Sep; 30(5):283-9. PubMed ID: 25856411
[TBL] [Abstract][Full Text] [Related]
17. [Lung cancer screening].
Sánchez González M
Radiologia; 2014; 56(5):385-9. PubMed ID: 23830728
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
19. Low-dose computed tomography (LDCT) versus other cancer screenings in early diagnosis of lung cancer: A meta-analysis.
Wang X; Liu H; Shen Y; Li W; Chen Y; Wang H
Medicine (Baltimore); 2018 Jul; 97(27):e11233. PubMed ID: 29979385
[TBL] [Abstract][Full Text] [Related]
20. The influence of selected factors on the attendance of the high-risk population in the early lung cancer detection program.
Zakrzewska A; Szczepanowska M; Książek J; Biadacz I; Dziedzic R; Jelitto-Górska M; Rzyman W
Pneumonol Alergol Pol; 2014; 82(1):25-31. PubMed ID: 24391068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
